Zlatko Trajanoski
Overview
Explore the profile of Zlatko Trajanoski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
20604
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Joerger M, et al.
Nature
. 2025 Feb;
639(8054):E18.
PMID: 40000750
No abstract available.
2.
Daum S, Decristoforo L, Mousa M, Salcher S, Plattner C, Hosseinkhani B, et al.
Mol Cancer
. 2025 Jan;
24(1):21.
PMID: 39819502
The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit...
3.
Bao L, Yu Y, Gonzalez-Acera M, Patankar J, Giessl A, Sturm G, et al.
Sci Transl Med
. 2025 Jan;
17(781):eadn8699.
PMID: 39813315
Dysregulation at the intestinal epithelial barrier is a driver of inflammatory bowel disease (IBD). However, the molecular mechanisms of barrier failure are not well understood. Here, we demonstrate dysregulated mitochondrial...
4.
Grubwieser P, Bock N, Soto E, Hilbe R, Moser P, Seifert M, et al.
Front Immunol
. 2024 Dec;
15:1508727.
PMID: 39691712
Introduction: Airway epithelial cells play a central role in the innate immune response to invading bacteria, yet adequate human infection models are lacking. Methods: We utilized mucociliary-differentiated human airway organoids...
5.
Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Joerger M, et al.
Nature
. 2024 Dec;
637(8048):1218-1227.
PMID: 39663448
Cancer immunotherapies with antibodies blocking immune checkpoint molecules are clinically active across multiple cancer entities and have markedly improved cancer treatment. Yet, response rates are still limited, and tumour progression...
6.
Scheiber A, Trebo M, Pittl A, Heidegger I, Hautz T, Oberhuber R, et al.
STAR Protoc
. 2024 Dec;
5(4):103475.
PMID: 39661509
The successful recovery of immune cells, particularly those with low mRNA content, by single-cell RNA sequencing (scRNA-seq) remains a significant challenge. Tissue dissociation and selection of the appropriate scRNA-seq technology...
7.
Horn V, Cancino C, Steinheuer L, Obermayer B, Fritz K, Nguyen A, et al.
Gastroenterology
. 2024 Sep;
168(2):327-343.
PMID: 39343250
Background & Aims: Despite the success of biological therapies in treating inflammatory bowel disease, managing patients remains challenging due to the absence of reliable predictors of therapy response. Methods: In...
8.
Zur Nedden S, Safari M, Weber D, Kuenkel L, Garmsiri C, Lang L, et al.
Metabolism
. 2024 Sep;
161():156039.
PMID: 39332493
Background And Aim: We recently identified protein kinase N1 (PKN1) as a master regulator of brain development. However, its function in the adult brain has not been clearly established. In...
9.
Lapuente-Santana O, Sturm G, Kant J, Ausserhofer M, Zackl C, Zopoglou M, et al.
iScience
. 2024 Aug;
27(8):110529.
PMID: 39161957
The cellular and molecular heterogeneity of tumors is a major obstacle to cancer immunotherapy. Here, we use a systems biology approach to derive a signature of the main sources of...
10.
Heidegger I, Frantzi M, Salcher S, Tymoszuk P, Martowicz A, Gomez-Gomez E, et al.
Eur Urol Oncol
. 2024 Jun;
PMID: 38851995
Background And Objective: While collagen density has been associated with poor outcomes in various cancers, its role in prostate cancer (PCa) remains elusive. Our aim was to analyze collagen-related transcriptomic,...